Full Text
The Full Text of this article is available as a PDF (105.4 KB).
Figure 1 .
Helicobacter pylori eradication rates with triple therapy comprising proton pump inhibitor (RBC = ranitidine bismuth citrate), clarithromycin, and a nitroimidazole for seven days. The numbers of the references from which the data are taken are given on the x axis.
Figure 2 .
Helicobacter pylori eradication rates with triple therapy comprising proton pump inhibitor (RBC = ranitidine bismuth citrate), clarithromycin, and amoxycillin for seven days. The numbers of the references from which the data are taken are given on the x axis. LAN 30, lansoprazole 15 mg twice daily; LAN 60, lansoprazole 30 mg twice daily; OME 40, omeprazole 20 mg twice daily; PAN 40, pantoprazole 40 mg once daily; PAN 80, pantoprazole 40 mg twice daily.
Figure 3 .
Helicobacter pylori eradication rates with triple therapy comprising proton pump inhibitor, amoxycillin, and metronidazole for seven days. The numbers of the references from which the data are taken are given on the x axis. OME 20, omeprazole 20 mg once daily; OME 40, omeprazole 40 mg once daily.
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bell G. D., Powell K. U., Burridge S. M., Bowden A. N., Rameh B., Bolton G., Purser K., Harrison G., Brown C., Gant P. W. Helicobacter pylori eradication: efficacy and side effect profile of a combination of omeprazole, amoxycillin and metronidazole compared with four alternative regimens. Q J Med. 1993 Nov;86(11):743–750. [PubMed] [Google Scholar]
- Borody T. J., Andrews P., Fracchia G., Brandl S., Shortis N. P., Bae H. Omeprazole enhances efficacy of triple therapy in eradicating Helicobacter pylori. Gut. 1995 Oct;37(4):477–481. doi: 10.1136/gut.37.4.477. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hosking S. W., Ling T. K., Chung S. C., Yung M. Y., Cheng A. F., Sung J. J., Li A. K. Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: randomised controlled trial. Lancet. 1994 Feb 26;343(8896):508–510. doi: 10.1016/s0140-6736(94)91460-5. [DOI] [PubMed] [Google Scholar]
- Lind T., Veldhuyzen van Zanten S., Unge P., Spiller R., Bayerdörffer E., O'Morain C., Bardhan K. D., Bradette M., Chiba N., Wrangstadh M. Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study. Helicobacter. 1996 Sep;1(3):138–144. doi: 10.1111/j.1523-5378.1996.tb00027.x. [DOI] [PubMed] [Google Scholar]
- Misiewicz J. J., Harris A. W., Bardhan K. D., Levi S., O'Morain C., Cooper B. T., Kerr G. D., Dixon M. F., Langworthy H., Piper D. One week triple therapy for Helicobacter pylori: a multicentre comparative study. Lansoprazole Helicobacter Study Group. Gut. 1997 Dec;41(6):735–739. doi: 10.1136/gut.41.6.735. [DOI] [PMC free article] [PubMed] [Google Scholar]
- de Boer W. A., Driessen W. M., Jansz A. R., Tytgat G. N. Quadruple therapy compared with dual therapy for eradication of Helicobacter pylori in ulcer patients: results of a randomized prospective single-centre study. Eur J Gastroenterol Hepatol. 1995 Dec;7(12):1189–1194. doi: 10.1097/00042737-199512000-00011. [DOI] [PubMed] [Google Scholar]
- de Boer W., Driessen W., Jansz A., Tytgat G. Effect of acid suppression on efficacy of treatment for Helicobacter pylori infection. Lancet. 1995 Apr 1;345(8953):817–820. doi: 10.1016/s0140-6736(95)92962-2. [DOI] [PubMed] [Google Scholar]